 
| IPAD-DB ID | C00077 | 
| Name | Resveratrol | 
| Category | Natural compounds | 
| 2D Structure |  | 
| 3D Structure | |
| Molecular Formula | C 1 4 H 1 2 O 3 | 
| Molecular Weight | 228.24g/mol | 
| IUPAC Name | 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1, 3-diol | 
| InChI | InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9, 15-17H/b2-1+ | 
| InChIKey | LUKBXSAWLPMMSZ-OWOJBTEDSA-N | 
| Canonical SMILES | C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O | 
| PubChem CID | 445154 | 
| DrugBank Accession Number | DB02709 | 
| CAS Registry Number | 501-36-0 | 
| Ki | - | 
| EC50 | - | 
| IC50 | 15.1 ( Aβ42) | 
| Inhibition | - | 
| Toxicity | - | 
| ROS(reactive oxygen species) | - | 
| Metal Chelating | - | 
| BBB(blood-brain barrier) | - | 
| Target Protein | Aβ | 
| Effects | - | 
| Research Models | - | 
| Main Source | - | 
| Ref. Link | 
| Molecular Weight(Computed by SwissADME) | 228.24 | 
| Hac(Computed by SwissADME) | 17 | 
| Volume(Computed by ADMETlab 2.0) | 241.503 | 
| Density(Computed by ADMETlab 2.0) | 0.944 | 
| nRing(Computed by ADMETlab 2.0) | 2 | 
| MaxRing(Computed by ADMETlab 2.0) | 6 | 
| nHet(Computed by ADMETlab 2.0) | 3 | 
| fChar(Computed by ADMETlab 2.0) | 0 | 
| nRig(Computed by ADMETlab 2.0) | 13 | 
| Flexibility(Computed by ADMETlab 2.0) | 0.154 | 
| Stero Centers(Computed by ADMETlab 2.0) | 0 | 
| LogS(Computed by ADMETlab 2.0) | -2.273 | 
| LogD(Computed by ADMETlab 2.0) | 3.363 | 
| logP(Computed by ADMETlab 2.0) | 2.97 | 
| TPSA(Computed by SwissADME) | 60.69 Ų | 
| Hbond Acceptor(Computed by SwissADME) | 3 | 
| Hbond Donor(Computed by SwissADME) | 3 | 
| Rotatable Bonds(Computed by SwissADME) | 2 | 
| GI Absorption(Computed by SwissADME) | High | 
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes | 
| P-gp Substrate(Computed by SwissADME) | No | 
| CYP1A2 Inhibitor(Computed by SwissADME) | Yes | 
| CYP2C19 Inhibitor(Computed by SwissADME) | Yes | 
| CYP2C9 Inhibitor(Computed by SwissADME) | No | 
| CYP2D6 Inhibitor(Computed by SwissADME) | Yes | 
| CYP3A4 Inhibitor(Computed by SwissADME) | No | 
| log Kp(Skin Permeation)(Computed by SwissADME) | -5.85 cm/s | 
| Lipinski(Computed by SwissADME) | Yes, 0 violation | 
| Ghose(Computed by SwissADME) | Yes | 
| Veber(Computed by SwissADME) | Yes | 
| Egan(Computed by SwissADME) | Yes | 
| Muegge(Computed by SwissADME) | Yes | 
| Bioavailability Score(Computed by SwissADME) | 0.55 |